Cannabinoids to Treat Serious Neurological and Inflammatory Conditions
Related Articles
Emerald Health Therapeutics Inc. (TSX.V: EMH) CEO Chris Wagner on Medical Marijuana Trends
March 21, 2018
admin
CEO Interview, Consumer
Comments Off on Emerald Health Therapeutics Inc. (TSX.V: EMH) CEO Chris Wagner on Medical Marijuana Trends
Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the […]
MassRoots, Inc. (OTC: MSRT) Offering turnkey solutions for cannabis industry
February 26, 2019
admin
CEO Interview, Consumer
Comments Off on MassRoots, Inc. (OTC: MSRT) Offering turnkey solutions for cannabis industry
Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.
October 17, 2018
admin
CEO Interview, Healthcare
Comments Off on Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.
Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]